Herold, Kevan C. et al
"A Single Course of Anti-CD3 Monoclonal Antibody hOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Diabetes." Diabetes
54.6
(2005):
1763-1769.
Web. 25 Feb. 2021.
